Part of the ICU Emergencies Hub — browse every related guide in one place.
Calcium-channel-blocker overdose is among the deadliest of the cardiovascular medication poisonings, and the sustained-release formulations make it worse: a patient can look deceptively stable for hours after swallowing extended-release verapamil, then crash as the drug slowly liberates. ICU nurses see these patients as bradycardic, hypotensive, and only slowly responsive to fluids and standard pressors — the hallmark of a poisoning that has to be treated around the blockade rather than through it.
L-type calcium channels let calcium into cardiac and vascular smooth muscle, and that calcium is what triggers contraction and sustains conduction. Block the channels and three things happen at once. The heart slows (the SA and AV nodes are calcium-dependent, so bradycardia and AV block appear), the heart weakens (less calcium means a weaker squeeze), and the vessels dilate (vascular smooth muscle relaxes, dropping systemic vascular resistance). The combination — a slow, weak pump feeding a dilated circuit — is why the hypotension is so severe and so hard to reverse.
The class splits by target. The non-dihydropyridines, verapamil and diltiazem, hit the heart hard and cause the classic bradycardic, low-output picture. The dihydropyridines, like amlodipine and nifedipine, are more vessel-selective, so their overdose can present with a fast reflex heart rate and vasodilatory shock resembling sepsis — but at very high doses that selectivity is lost and they too depress the heart. Knowing which agent was taken predicts whether you are fighting a bradycardic pump failure or a vasodilated distributive shock, or both.
Presentation is bradycardia with hypotension, altered mental status as perfusion fails, and a rising lactate. A notable and dangerous feature relative to beta-blocker overdose is that mental status is often relatively preserved until late — patients can be talking while their pressure is collapsing — because these drugs are not as CNS-penetrant. That can lull a team into underestimating the ingestion. The other trap is the sustained-release preparation: with extended-release verapamil or diltiazem, the peak effect can be delayed many hours, so a patient who looks fine on arrival still needs prolonged monitoring, aggressive gut decontamination, and whole-bowel irrigation in the right setting.
As with beta-blocker overdose, the therapies are layered, not tried in sequence. Support the airway, give fluids for the vasodilation (cautiously, because the heart is weak), and start the antidotes.
Giving calcium — calcium chloride (central line preferred, it is caustic to veins) or calcium gluconate — partially overcomes the channel blockade by raising the calcium gradient. It helps blood pressure and conduction but is often incompletely effective in severe poisoning, and repeated dosing requires watching the ionized calcium. It is a first-line move but rarely the whole answer.
This is the treatment most associated with survival in serious calcium-channel-blocker overdose. It improves the poisoned heart's contractility and its ability to use glucose for fuel, and it directly counters the toxin-induced insulin deficiency. The doses are far above diabetic dosing and demand meticulous glucose and potassium management — the full protocol and the nursing tightrope are covered in our high-dose insulin euglycemia guide. Because these patients start hyperglycemic, they may need little or no dextrose at first, but that flips as the insulin takes hold, so glucose checks stay frequent throughout.
High-dose norepinephrine and epinephrine are titrated for the vasodilation and pump failure. Atropine is usually tried for the bradycardia and usually disappoints. Intravenous lipid emulsion is a rescue option for the lipophilic agents. Pacing is attempted but frequently fails to capture. The sickest, refractory patients are candidates for ECMO or other mechanical circulatory support, which supports perfusion while the enormous drug burden slowly clears — a strategy with genuinely good outcomes in centers that can deploy it quickly.
The bedside work mirrors beta-blocker overdose with a calcium twist. Run frequent glucose checks — the patient may swing from hyperglycemic to needing dextrose once high-dose insulin is on board. Track potassium, which insulin shifts intracellularly; replace cautiously per the IV potassium guide and remember a shift is not the same as a deficit. Monitor ionized calcium with repeated calcium dosing to avoid overshooting. Give calcium chloride through a central line when possible and watch the peripheral site if it must run peripherally. Keep continuous telemetry and an arterial line, follow serial lactates as your perfusion readout, and stay ahead of the delayed-release crash by not relaxing vigilance just because the first hours were calm.
Calcium-channel-blocker overdose is a bradycardic, vasodilated, low-output shock that resists ordinary resuscitation because the drug has removed the calcium the heart and vessels run on. The blood sugar is the tell — hyperglycemia points here rather than to a beta-blocker — and the treatments that save lives are calcium, high-dose insulin euglycemic therapy, high-dose vasopressors, and, in refractory cases, lipid emulsion and mechanical support. For the ICU nurse, the two habits that matter most are respecting the delayed crash of sustained-release formulations and running the glucose-and-potassium monitoring that keeps high-dose insulin safe.
Related: Beta-blocker overdose | High-dose insulin euglycemia | Digoxin toxicity | Unstable bradycardia | Hyperkalemia emergency
Get The ICU Notebook Newsletter
Clinical tools and career insights for ICU nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.